Baig Saqib H, Yoo Erika J
Division of Pulmonary, Allergy and Critical Care Medicine, Jane and Leonard Korman Respiratory Institute, Sidney Kimmel Medical College, Thomas Jefferson University, 211 South 9th Street, Suite 401, Philadelphia, PA 19107, USA.
Life (Basel). 2024 Jan 21;14(1):156. doi: 10.3390/life14010156.
Idiopathic pulmonary fibrosis is a chronic progressive lung disease of unknown cause with a high associated mortality. We aimed to compare the impact of chronic medical conditions on hospital outcomes of patients with acute exacerbations of idiopathic pulmonary fibrosis (AE-IPF).
This was a retrospective cohort study using the NIS database from 2016 to 2018. We included patients aged 60 and older hospitalized in academic medical centers with the diagnoses of IPF and acute respiratory failure. We examined factors associated with hospital mortality and length of stay (LOS) using survey-weighted multivariate logistic and negative binomial regression.
Out of 4975 patients with AE-IPF, 665 (13.4%) did not survive hospitalization. There was no difference in the mean age between survivors and non-survivors. Patients were more likely to be male, predominantly white, and have Medicare coverage. Most non-survivors were from households with higher median income. Hospital LOS was longer among non-survivors than survivors (9.4 days vs. 9.8 days; < 0.001). After multivariate-logistic regression, diabetes was found to be protective (aOR 0.62, 95% CI 0.50-0.77; < 0.0001) while chronic kidney disease (CKD) conferred a significantly higher risk of death after AE-IPF (aOR 6.85, 95% CI 1.90-24.7; = 0.00). Our multivariate adjusted negative binomial regression model for LOS identified obesity (IRR 0.85, 95% CI 0.76-0.94; ≤ 0.00) and hypothyroidism (IRR 0.90, 95% CI 0.83-0.98; = 0.02) to be associated with shorter hospital LOS.
Our results suggest that CKD is a significant contributor to hospital mortality in AE-IPF, and diabetes mellitus may be protective. Obesity and hypothyroidism are linked with shorter hospital LOS among patients hospitalized with AE-IPF in US academic medical centers.
特发性肺纤维化是一种病因不明的慢性进行性肺部疾病,死亡率较高。我们旨在比较慢性疾病对特发性肺纤维化急性加重期(AE-IPF)患者住院结局的影响。
这是一项回顾性队列研究,使用了2016年至2018年的国家住院样本(NIS)数据库。我们纳入了年龄在60岁及以上、在学术医疗中心住院且诊断为IPF和急性呼吸衰竭的患者。我们使用调查加权多变量逻辑回归和负二项回归来检查与医院死亡率和住院时间(LOS)相关的因素。
在4975例AE-IPF患者中,665例(13.4%)未存活至出院。存活者和非存活者的平均年龄无差异。患者更可能为男性,主要是白人,且有医疗保险覆盖。大多数非存活者来自中位数收入较高的家庭。非存活者的住院LOS比存活者更长(9.4天对9.8天;P<0.001)。多变量逻辑回归后,发现糖尿病具有保护作用(调整后比值比[aOR]0.62,95%置信区间[CI]0.50-0.77;P<0.0001),而慢性肾脏病(CKD)在AE-IPF后死亡风险显著更高(aOR 6.85,95%CI 1.90-24.7;P=0.00)。我们针对LOS的多变量调整负二项回归模型确定肥胖(发病率比值比[IRR]0.85,95%CI 0.76-0.94;P≤0.00)和甲状腺功能减退(IRR 0.90,95%CI 0.83-0.98;P=0.02)与较短的住院LOS相关。
我们的结果表明,CKD是AE-IPF患者医院死亡率的重要因素,而糖尿病可能具有保护作用。在美国学术医疗中心,肥胖和甲状腺功能减退与AE-IPF住院患者较短的住院LOS相关。